BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2005
View Archived Issues
Medivir reflects on Q3 developments
Read More
Targeting mGluR1 for epilepsy
Read More
USP7: new target for cancer with inhibitors identified at Hybrigenics
Read More
Bioreductive prodrugs facilitate selective targeting of hypoxic tumor regions
Read More
Novel tumor-localizing agents described
Read More
R-112 disappoints in phase II comparative study in allergic rhinitis
Read More
Bausch & Lomb and PTC Therapeutics collaborate in ophthalmology
Read More
ArQule seeks to begin phase I studies with ARQ-197
Read More
Wyeth awarded new contract for development of therapeutic HIV vaccines
Read More
Alza modifies U.S. clinical development program for OROS Hydromorphone
Read More
Second approvable letter for diquafosol tetrasodium ophthalmic solution
Read More
New phase I study investigates INNO-105 in advanced solid malignancies
Read More
Private equity financing to support NeurogesX' development of Transacin
Read More
Bausch & Lomb licenses compounds from Cephalon for ophthalmic use
Read More
Provectus studies PV-10 for breast cancer in phase I trial
Read More
ACP-103 reduces haloperidol-induced akathisia in patients with schizophrenia
Read More
Phase I data on chemotherapeutic RH1 presented
Read More
S-18407, a novel alpha4beta1 integrin inhibitor, effective in murine Lyme arthritis
Read More
Opticin found to induce antiangiogenic effects in vitro and in vivo
Read More
New cancer vaccine activates host immune response
Read More
New agents described for treating cardiovascular disorders
Read More
Novel compounds with potential for inflammatory disorders imparted in patents
Read More
Recent patents report new treatments for thrombotic disorders
Read More
Preclinical studies reveal activity of BMS-354825 in various cancer types
Read More